Oral News and Research

RSS

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Researchers at UT Southwestern Medical Center at Dallas have utilized an animal model to trace how the virus that causes AIDS in humans may enter and spread throughout the body following an oral exposure.

3 Dec 2004

Guidelines needed for the use of androgens for women with sexual dysfunction

The Endocrine Society, which represents more than 12,000 endocrinologists who are specially trained to diagnose, treat and conduct basic and clinical research on complex hormonal disorders, has called for new clinical guidelines on the use of androgens in women/female sexual dysfunction.

3 Dec 2004

Potential vaccine for the deadly toxin ricin

A potential vaccine for the deadly toxin ricin, a "Category B" biological agent, will enter the first phase of clinical testing in coming weeks at UT Southwestern Medical Center at Dallas.

30 Nov 2004

Adding a commonly used dietary supplement to antidepressants may improve treatment

Massachusetts General Hospital (MGH) researchers have found that adding the nutritional supplement SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.

30 Nov 2004

Citrus fruits offer promise in fighting childhood cancer

Orange juice and cancer don't mix. In fact, the popular citrus drink could become a cocktail to prevent or stop the deadly disease in humans.

30 Nov 2004

Oral administration of saline spray may stop spread of influenza, tuberculosis, and SARS

Some individuals exhale many more pathogen-laden droplets than others in the course of ordinary breathing, scientists have found, but oral administration of a safe saline spray every six hours might slash exhalation of germs in this group by an average 72 percent.

29 Nov 2004

Stress affects molecules believed to play a key role in cellular aging

There have been many studies that have shown that your health is greatly affected by how you react to stressful events in life-setbacks or deadlines at work, conflicts and losses at home.

29 Nov 2004

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Genentech and Roche today announced that a randomized Phase III study of Avastin™ (bevacizumab) plus the FOLFOX4 chemotherapy regimen (oxaliplatin/5-FU/leucovorin), compared to FOLFOX4 alone, in second-line metastatic colorectal cancer patients achieved its primary endpoint of improving overall survival.

29 Nov 2004

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales. Smoking and drinking cause most cancers of the mouth, lip and tongue (oral cavity), throat and voice box.

24 Nov 2004

Positive results of study with human lactoferrin

Pharming Group N.V. announced today the positive results from a key study with recombinant human lactoferrin (rhLF). The Company will use these results for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.

24 Nov 2004

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Current guidelines recommend the use of oral NSAIDs in the treatment of knee osteoarthritis and they are used regularly by half of all patients with painful osteoarthritis.

23 Nov 2004

FDA approves Tarceva (erlotinib)

OSI Pharmaceuticals and Genentech have announced that the U.S. Food and Drug Administration (FDA) has approved, after priority review, Tarceva (erlotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.

20 Nov 2004

What makes beer taste so darn good to men, but vile to most women?

What makes beer taste so darn good to men, but vile to most women? Some oral sensations are under genetic control and new research suggests that these influences on taste perception could help determine the risk of excess alcohol consumption.

16 Nov 2004

Oral contraception can prevent knee injuries as well as unwanted pregnancies

In 1960 the first oral contraception, Enovid-10, was launched in the US market, known as the “pill”. Women were finally enthused about a form of contraception marketed as “safe and effective” and readily used the pill. Within two years oral contraception was used by over 1.2 million women and the numbers continued to rise.

16 Nov 2004

Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

Kids who outgrow peanut allergy have a slight chance of recurrence, but researchers from the Johns Hopkins Children's Center report that the risk is much lower in children who frequently eat peanuts or peanut products.

11 Nov 2004

Treating period pain with Chinese medicine

It's news that could have women everywhere throwing away their hot water bottles, painkillers and Tim Tams. A University of Western Sydney study is set to discover if ancient Chinese medicine can provide relief from the monthly cramping, back pain and bloating associated with menstruation.

11 Nov 2004

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

An "old" drug has unique benefits for patients with acute myocardial infarction (AMI; commonly known as heart attack), a finding that may contribute to a new understanding of how heart attacks develop, according to an article in the September/October American Journal of Therapeutics.

10 Nov 2004

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.

9 Nov 2004

Cranberry juice may help prevent gum disease

New research presented at a recent symposium suggests that cranberry juice may help prevent certain oral health problems, including diseases of the gums and teeth.

9 Nov 2004

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

During the current flu vaccine shortage, the Centers for Disease Control and Prevention, Department of Health and Human Services, has issued guidance recommending the use of certain alternative antiviral medications.

8 Nov 2004

Oral News and Research

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Guidelines needed for the use of androgens for women with sexual dysfunction

Potential vaccine for the deadly toxin ricin

Adding a commonly used dietary supplement to antidepressants may improve treatment

Citrus fruits offer promise in fighting childhood cancer

Oral administration of saline spray may stop spread of influenza, tuberculosis, and SARS

Stress affects molecules believed to play a key role in cellular aging

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales

Positive results of study with human lactoferrin

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

FDA approves Tarceva (erlotinib)

What makes beer taste so darn good to men, but vile to most women?

Oral contraception can prevent knee injuries as well as unwanted pregnancies

Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

Treating period pain with Chinese medicine

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

Cranberry juice may help prevent gum disease

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News